KAM
Kazazian Asset Management Portfolio holdings
AUM
$72.4M
This Quarter Return
+4.85%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$97.9M
AUM Growth
+$97.9M
(+20%)
Cap. Flow
+$14.5M
Cap. Flow
% of AUM
14.84%
Top 10 Holdings %
Top 10 Hldgs %
51.86%
Holding
86
New
16
Increased
49
Reduced
9
Closed
4
Top Buys
| 1 |
CS
Credit Suisse Group
CS
|
$1.93M |
| 2 |
Barclays
BCS
|
$1.52M |
| 3 |
NS
NuStar Energy L.P.
NS
|
$1.51M |
| 4 |
Nektar Therapeutics
NKTR
|
$1.17M |
| 5 |
Bausch Health
BHC
|
$1.04M |
Top Sells
| 1 |
Biogen
BIIB
|
$405K |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$357K |
| 3 |
Sarepta Therapeutics
SRPT
|
$265K |
| 4 |
Chipotle Mexican Grill
CMG
|
$265K |
| 5 |
IAC Inc
IAC
|
$243K |
Sector Composition
| 1 | Healthcare | 24.97% |
| 2 | Consumer Discretionary | 11.02% |
| 3 | Financials | 10.96% |
| 4 | Communication Services | 6.9% |
| 5 | Energy | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cleveland-Cliffs
CLF
$5.13B
| $95K | 0.1% |
13,161
+1,047
| +9% | +$7.56K |
|
|
OMED
77
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $80K | 0.08% |
+19,512
| New | +$80K |
|
78
Rocket Pharmaceuticals
RCKT
$358M
| $68K | 0.07% |
+26,016
| New | +$68K |
|
79
Minerva Neurosciences
NERV
$16.2M
| $63K | 0.06% |
+10,410
| New | +$63K |
|
|
MTL.PR
80
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
| $47K | 0.05% |
44,298
| – | – |
|
81
Equus Total Return
EQS
$31.1M
| $46K | 0.05% |
19,073
| – | – |
|
|
GMO
82
DELISTED
General Moly, Inc.
GMO
| $7K | 0.01% |
20,895
| – | – |
|
83
Global X MSCI Greece ETF
GREK
$304M
| – | – |
-14,400
| Closed | -$136K |
|
84
Pacira BioSciences
PCRX
$1.22B
| – | – |
-5,247
| Closed | -$197K |
|
|
85
Sarepta Therapeutics
SRPT
$2.05B
| – | – |
-5,832
| Closed | -$265K |
|
|
IMGN
86
DELISTED
Immunogen Inc
IMGN
| – | – |
-46,644
| Closed | -$357K |
|